Aspen, ZAE000066692

Aspen stock has a December 3 AGM and sits 5.80 percent below its high

Published on 10/15/2026 at 19:31 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Aspen's price-to-earnings ratio is 26.27 on October 15, 2026. Aspen stock costs EUR 8.40 on October 15, 2026, up 1.93 percent on the JSE.

Scheduled date and valuation

  • Aspen's annual general meeting is scheduled for December 3, 2026.
  • The stock's price-to-earnings ratio was 26.27 on October 15, 2026.
  • Aspen stock costs EUR 8.40 at Lang & Schwarz on October 15, 2026 at 7:17 p.m. CEST, up 1.93 percent on the JSE.
Aspen, ZAE000066692, Illustration mit AI erstellt.

Aspen (ZAE000066692) has its annual general meeting scheduled for December 3, 2026, giving investors the next formal date on the company's calendar, according to Moneyweb. Aspen stock was trading at EUR 8.40 at Lang & Schwarz on October 15, 2026 at 7:17 p.m. CEST, while the JSE quote was up 1.93 percent on the day.

Operating scale supports the valuation

Aspen's investor-relations page identifies the company as a JSE-listed specialty and branded pharmaceutical group with 23 manufacturing facilities across 15 sites. Its portfolio spans sterile products, oral solid doses, liquids, semi-solids, biological products and active pharmaceutical ingredients, according to Aspen Pharmacare.

Price position and valuation

The JSE quotation stood at ZAc 15,657.00 on October 15, 2026, with a day high of ZAc 15,995.00 and a day low of ZAc 15,254.00. The 52-week range ran from ZAc 9,070.00 to ZAc 16,621.00, leaving the stock 5.80 percent below its high. Trading volume reached 2,151,768 shares, compared with an average of 1,586,264 shares.

The market capitalization was ZAR 68.7 billion as of October 15, 2026, and the price-to-earnings ratio was 26.27. The annual results page reports normalised EBITDA of ZAR 7.7 billion for fiscal year 2026, up 10 percent, while free cash flow before dividends reached ZAR 3.8 billion, according to Aspen Pharmacare.

Calendar date for shareholders

The December 3, 2026 AGM will be held at Aspen's head office in Durban. The record date is November 27, 2026, and the last trading day for voting eligibility is November 24, 2026, according to the AGM notice. The dates give the market a defined near-term calendar point while the valuation remains tied to earnings delivery and cash generation.

Trading remains below the yearly high

The euro quotation was trading at EUR 8.40 at Lang & Schwarz on October 15, 2026 at 7:17 p.m. CEST, with the JSE session showing a 1.93 percent daily gain. The stock remained below its ZAc 16,621.00 52-week high, while its ZAc 15,657.00 JSE price sat above the ZAc 9,070.00 low.

The further course of trading is shown by the continuously updated real-time quote of Aspen stock.

Aspen stock at a glance

  • Company: Aspen Pharmacare Holdings Limited
  • ISIN: ZAE000066692
  • Ticker: APN
  • Primary exchange: JSE
  • Price Lang & Schwarz (as of October 15, 2026, 7:17 p.m. CEST): EUR 8.40
  • JSE price (as of October 15, 2026): ZAc 15,657.00
  • Change on the JSE: plus 1.93 percent
  • Market capitalization: ZAR 68.7 billion (as of October 15, 2026)
  • 52-week range: ZAc 9,070.00-ZAc 16,621.00 (as of October 15, 2026)
  • Sector / Industry: Health Care / Pharmaceuticals
  • Next shareholder date: December 3, 2026 - annual general meeting

Market context: Latest market reports.

More news and analyses on Aspen stock

Disclaimer...
en | ZAE000066692 | ASPEN | boerse | 70331598 | bgmi